Director's Share Dealing

For immediate release

26 September 2012

Clinigen Group plc (the "Company")

Director's Share Dealing

Clinigen Group plc, the global specialty pharmaceuticals and pharmaceutical services business, announces that it has been notified on 25 September 2012 that on 25 September 2012, Ian Nicholson, a Non-Executive Director of the Company, bought 10,000 ordinary shares of 0.1 pence each in the Company at a price of 164 pence per share.

Following this transaction, Mr. Nicholson's total beneficial interest in the Company is 10,000 ordinary shares, representing approximately 0.01 per cent. of the current issued share capital of the Company.

-Ends-

For further information, please contact: